Swedish Cancer Institute at Edmonds opens to the public at an April 17 ribbon-cutting ceremony on the Swedish/Edmonds campus. (Left to right) David Loud, aide from Congressman Jim McDermott, M.D.; Swedish Cancer Institute Medical Oncologist Richard McGee, M.D.; Swedish/Edmonds Chief Executive Dave Jaffe; and Swedish Cancer Institute Executive Director Thomas D. Brown, M.D., MBA, cut the ribbon during the event that attracted 250 visitors. The two-story facility, located at 21632 Highway 99 in Edmonds, provides high-quality and comprehensive medical oncology to patients through an infusion unit, laboratory, pharmacy, and access to Swedish’s electronic medical record system.
EDMONDS, WASH., March 21, 2013 – Swedish Health Services will open a new outpatient cancer center at the Edmonds campus on Monday, April 1, 2013 in response to the growing need for medical oncology and infusion (chemotherapy) services in the south Snohomish and north King County area. The new two-story, 17,102-square-foot facility is anticipated to handle as many as 175 patient visits each day and provide increased access to cancer-care services for people living north of Seattle.
New Cancer Center to Open April 1 at Swedish/Edmonds; Outpatient Facility to Provide Medical Oncology, Infusion Services Close to Home
I often get asked why can’t a woman just get a breast MRI rather than a mammogram. The imaging tests that we do for breast cancer screening and evaluation of abnormalities have different strengths and weaknesses.
Mammograms are very useful as a screening tool. They can be done quickly and read efficiently by the breast radiologist. They have minimal radiation exposure. They can be done by a mobile coach in locations that are more convenient to patients. They are excellent for identifying abnormal calcium deposits within the breast tissue and for seeing disrupted tissue and masses. They may be less effective in women who have dense breast tissue but the digital techniques have helped some with that.
Ultrasound is a great tool for evaluating a mass or tissue asymmetry found on mammograms. It can distinguish between a benign appearing solid mass, a fluid filled cyst, a mass that is suspicious for cancer, or normal appearing breast tissue. There is no radiation exposure. It is less reliable as a screening tool because it can be dependent on the skill of the physician or technologist doing the procedure. It is possible to miss abnormalities or to mis-interpret normal findings as abnormal. There are studies underway evaluating using an automated version of ultrasound as a screening test but the results are not conclusive and this is not considered ready for standard practice.
Breast MRI is a highly sensitive test that is very dependent on...
SEATTLE – May 29, 2012 – Swedish Cancer Institute (SCI) is set to open its new True Family Women’s Cancer Center to patients on Tuesday, June 5. Carefully designed with the female cancer patient in mind, the new 23,600-square-foot women’s cancer center gives Swedish Cancer Institute the ability to consolidate most of its services for treating women’s cancers into one facility. The new center acts as a treatment hub where women are guided through personalized and coordinated multidisciplinary treatment of their cancer, including disease-specific education and holistic support activities.
SEATTLE, Feb. 23, 2012 – Based on a study of nearly 2,000 breast-cancer patients, researchers at the Swedish Cancer Institute say that, in women between the ages of 40 and 49, breast cancers detected by mammography have a better prognosis. The study appears in the March issue of Radiology.
“In our study, women aged 40 to 49 whose breast cancer was detected by mammography were easier to treat and had less recurring disease and mortality, because their cancer was found at an earlier stage,” Henry Kaplan, M.D., medical oncologist with Swedish Cancer Institute (SCI).